Skip to main content
Top
Published in: Pediatric Nephrology 7/2009

01-07-2009 | Original Article

Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus

Authors: Reyhan El-Kares, Pierre-Alain Hueber, Miriam Blumenkrantz, Diana Iglesias, Kim Ma, Nada Jabado, Daniel G. Bichet, Paul Goodyer

Published in: Pediatric Nephrology | Issue 7/2009

Login to get access

Abstract

We report on a child with X-linked nephrogenic diabetes insipidus (NDI) who developed Wilms tumor (WT). Nephrogenic diabetes insipidus is caused by mutations of the arginine vasopressin receptor (AVPR2) or aquaporin-II (AQP2) genes. Wilms tumor is also genetically heterogeneous and is associated with mutations of WT1 (15–20%), WTX (20–30%) and other loci. The boy presented at 5 months with failure to thrive, polyuria, hypernatremia and abdominal mass. Analysis of leukocyte DNA showed a novel missense mutation (Q174H) of the AVPR2 gene, which was not present in his mother. In cells (WitS) isolated from the tumor, WTX mRNA expression and coding sequence were intact. However, we identified a 44-kb homozygous deletion of the WT1 gene spanning exons 4 to 10. The WT1 deletion was not present in leukocyte DNA from the patient or his mother. We also noted strong β-catenin (CTNNB1) expression in the tumor cells and identified a heterozygote missense Ser45Cys mutation of exon 3 of CTNNB1. However, the mutation was absent both in the constitutional DNA of the patient and his mother. The concurrence of WT and NDI has not been previously reported and may be unrelated. Nevertheless, this case nicely illustrates the sequence of events leading to sporadic Wilms tumor.
Literature
1.
go back to reference Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS (1997) Identical genetic changes in different histologic components of Wilms’ tumors. J Natl Cancer Inst 89:1148–1152CrossRef Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS (1997) Identical genetic changes in different histologic components of Wilms’ tumors. J Natl Cancer Inst 89:1148–1152CrossRef
2.
go back to reference Knudson AG Jr, Strong LC (1972) Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 48:313–324PubMed Knudson AG Jr, Strong LC (1972) Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 48:313–324PubMed
3.
go back to reference Rose EA, Glaser T, Jones C, Smith CL, Lewis HW, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE (1990) Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms’ tumor gene. Cell 60:495–508CrossRef Rose EA, Glaser T, Jones C, Smith CL, Lewis HW, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE (1990) Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms’ tumor gene. Cell 60:495–508CrossRef
4.
go back to reference Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447CrossRef Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447CrossRef
6.
go back to reference Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288–6292PubMed Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288–6292PubMed
7.
go back to reference Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315:642–645CrossRef Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315:642–645CrossRef
8.
go back to reference Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233–235CrossRef Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233–235CrossRef
9.
go back to reference Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55:278–286PubMedPubMedCentral Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55:278–286PubMedPubMedCentral
10.
go back to reference Fujiwara TM, Morgan K, Bichet DG (1996) Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 134:675–677CrossRef Fujiwara TM, Morgan K, Bichet DG (1996) Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 134:675–677CrossRef
11.
go back to reference van den Ouweland AM, Knoop MT, Knoers VV, Markslag PW, Rocchi M, Warren ST, Ropers HH, Fahrenholz F, Monnens LA, van Oost BA (1992) Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics 13:1350–1352CrossRef van den Ouweland AM, Knoop MT, Knoers VV, Markslag PW, Rocchi M, Warren ST, Ropers HH, Fahrenholz F, Monnens LA, van Oost BA (1992) Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics 13:1350–1352CrossRef
12.
go back to reference van Lieburg AF, Verdijk MA, Knoers VV, van Essen AJ, Proesmans W, Mallmann R, Monnens LA, van Oost BA, van Os CH, Deen PM (1994) Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55:648–652PubMedPubMedCentral van Lieburg AF, Verdijk MA, Knoers VV, van Essen AJ, Proesmans W, Mallmann R, Monnens LA, van Oost BA, van Os CH, Deen PM (1994) Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55:648–652PubMedPubMedCentral
13.
go back to reference Cowell JK (1980) Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. J Natl Cancer Inst 65:955–961PubMed Cowell JK (1980) Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. J Natl Cancer Inst 65:955–961PubMed
14.
go back to reference Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972–3977CrossRef Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972–3977CrossRef
15.
go back to reference Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74:679–691CrossRef Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74:679–691CrossRef
16.
go back to reference Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A (1999) YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126:1845–1857PubMed Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A (1999) YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126:1845–1857PubMed
17.
go back to reference Rivera MN, Haber DA (2005) Wilms’ tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5:699–712CrossRef Rivera MN, Haber DA (2005) Wilms’ tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5:699–712CrossRef
18.
go back to reference Hanson J, Gorman J, Reese J, Fraizer G (2007) Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 12:2279–2290CrossRef Hanson J, Gorman J, Reese J, Fraizer G (2007) Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 12:2279–2290CrossRef
19.
go back to reference Fukuzawa R, Heathcott RW, More HE, Reeve AE (2007) Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies. J Clin Pathol 60:1013–1016CrossRef Fukuzawa R, Heathcott RW, More HE, Reeve AE (2007) Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies. J Clin Pathol 60:1013–1016CrossRef
20.
go back to reference Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D’Agati V, Licht JD, Tycko B (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol 165:1943–1953CrossRef Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D’Agati V, Licht JD, Tycko B (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol 165:1943–1953CrossRef
21.
go back to reference Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms’ tumors. Cancer Res 59:3880–3882PubMed Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms’ tumors. Cancer Res 59:3880–3882PubMed
22.
go back to reference Koesters R, von Knebel Doeberitz M (2003) The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198:123–138CrossRef Koesters R, von Knebel Doeberitz M (2003) The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198:123–138CrossRef
23.
go back to reference Lolait SJ, O’Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336–339CrossRef Lolait SJ, O’Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336–339CrossRef
24.
25.
go back to reference Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM (2000) Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 11:1044–1054PubMed Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM (2000) Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 11:1044–1054PubMed
26.
go back to reference Beckwith JB (1998) Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 79:268–273CrossRef Beckwith JB (1998) Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 79:268–273CrossRef
27.
go back to reference Hueber PA, Fukuzawa R, El-Kares R, Chu LL, Blumenkrantz M, He S, Anaka MR, Reeve AE, Eccles MR, Jabado N, Iglesias DM, Goodyer PR (2008) PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms Tumors with myogenic phenotype. Pediatr Dev Pathol doi:https://doi.org/10.2350/08-05-0466.1 CrossRef Hueber PA, Fukuzawa R, El-Kares R, Chu LL, Blumenkrantz M, He S, Anaka MR, Reeve AE, Eccles MR, Jabado N, Iglesias DM, Goodyer PR (2008) PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms Tumors with myogenic phenotype. Pediatr Dev Pathol doi:https://​doi.​org/​10.​2350/​08-05-0466.​1 CrossRef
Metadata
Title
Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus
Authors
Reyhan El-Kares
Pierre-Alain Hueber
Miriam Blumenkrantz
Diana Iglesias
Kim Ma
Nada Jabado
Daniel G. Bichet
Paul Goodyer
Publication date
01-07-2009
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-009-1147-4

Other articles of this Issue 7/2009

Pediatric Nephrology 7/2009 Go to the issue